NOVEL SIROLIMUS-ELUTING STENT WITH UNIQUE FUSION COATING FOR TREATMENT OF PATIENTS WITH DIABETES MELLITUS

2018 ◽  
Vol 71 (11) ◽  
pp. A1121
Author(s):  
Sameer Dani
2011 ◽  
Vol 4 (4) ◽  
pp. 452-459 ◽  
Author(s):  
Steffen Desch ◽  
Denis Schloma ◽  
Sven Möbius-Winkler ◽  
Sandra Erbs ◽  
Stephan Gielen ◽  
...  

2007 ◽  
Vol 97 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Frank D. Weber ◽  
Henrik Schneider ◽  
Marcus Wiemer ◽  
Thomas Pfannebecker ◽  
Ulrich Tebbe ◽  
...  

2020 ◽  
Author(s):  
Ridhima Goel ◽  
Rishi Chandiramani ◽  
Roxana Mehran

Diabetes mellitus (DM) is a rising global epidemic affecting more than 10% of the world population and predisposes patients to develop highly progressive and complex coronary artery disease. Despite numerous advancements in percutaneous coronary intervention procedural techniques and coronary stent platforms, clinical outcomes in DM patients have improved little compared with non-DM patients. Abluminus DES+, a biodegradable polymer sirolimus-eluting stent deployed with a drug-coated balloon, has been specifically designed to provide adequate coverage for DM patients and reduce adverse clinical outcomes.


Sign in / Sign up

Export Citation Format

Share Document